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Introduction
Even though initial research into diffusion-weighted 
imaging (DWI) applications focused on the central nervous 
system (CNS) (1-4), there now is a growing amount of 
research extending to other systems. Applications of 
DWI in the musculoskeletal system have come to include 
assisting in differentiating vertebral compression fractures 
vs. malignant fractures (5), degenerative changes (6,7), 
monitoring tumor response to therapy (8), differentiating 
degenerative vs. infectious processes (9), malignant vs. 
infectious processes (10), and characterization of soft-tissue 
and bone tumors (11). The goal of this article is to provide 
a brief overview of the recent advancements and studies in 
the applications of DWI to the musculoskeletal system in 
the context of the authors’ institutional experiences.
Image acquisition and interpretation
The single shot echo planar imaging (SS-EPI) technique 
is the most commonly used sequence in DWI, providing 
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not only rapid image acquisition but reduced motion 
artifacts (12). Although the mechanics behind DWI 
have not been elucidated entirely (13), it is a non-
invasive method which measures the Brownian motion of 
water in its microscopic environment. This principle is 
exploited to detect and monitor the cellularity of a variety 
of pathologies. The signal obtained reflects the water 
content of the tissue, which is influenced by both perfusion 
and diffusion making image interpretation difficult. A 
diffusion weighted image is created by applying diffusion 
sensitizing gradients to a T2-weighted image, where the 
parameters of the sensitizing gradient are determined by 
the b value. With a b value of 0, the image appears as a T2-
weighted image and a progressive increase in the b value 
begins to suppress the perfusion effect, with only highly 
cellular tissues remaining bright at high b values (13). 
A hyperintense signal on DWI corresponds to an area where 
water motion is restricted and is not able to move out of 
the image plane. Because extracellular fluid motion is less 
restricted in comparison to intracellular fluid motion, more 
extracellular fluid will result in decreased signal. In contrast, 
an increased signal correlates to increased cellularity of 
the tissue because intracellular fluid motion is impeded by 
organelles (11,14).
In conjunction with DWIs, apparent diffusion coefficient 
maps (ADC) are sometimes given, quantify the effect of 
diffusion restriction. ADC calculation requires at least 
two DWIs at different b values and in contrast to DWI, 
stationary water appears hypointense on ADC maps 
(i.e., reduced diffusion) and hyperintense where there is 
increased water diffusion. ADC values in cells are much 
lower than in free standing water because cellular structures 
impede the diffusion of water. With low b values, the 
perfusion component accounts for a larger proportion of the 
signal intensity on ADC maps whereas diffusion dominates 
at higher b values. These can be reported as ADCslow and 
ADCfast components but generally, only a total ADC value is 
given (13).
For proper interpretation of DWIs and ADC maps, 
clinical correlation is essential. Tumors generally have 
restricted diffusion compared to healthy tissues due to 
enlarged nuclei and increased cellularity resulting in 
decreased extracellular volumes. The restricted diffusion 
leads to increased signal on DWI and decreased signal on 
ADC map. Depending on the features of the malignancy 
and the treatment response, this pattern may change in 
the course of the pathology. Rapidly growing tumors can 
outgrow their vascular supply or treatment of tumors can 
lead to necrosis, causing decreased signal intensity on high 
b value images and increased ADC values. Certain tissues 
with long T2 relaxation times can cause increased signal 
on DWI images even though they are not due to decreased 
diffusion. This process is termed the “T2-shine through 
effect” and leads to an increased signal on both, DWI 
and ADC maps (13), therefore comparison of the two is 
essential.
Malignancies of soft-tissue and bone
Morphological magnetic resonance imaging (MRI) 
techniques are applied in the workup of certain soft-tissue 
tumors and characteristic imaging findings are helpful to 
narrow down the differential diagnosis. Investigations using 
DWI as a functional MR sequence have been focusing 
on developing qualitative and quantitative criteria for 
musculoskeletal tumors. One study found that defining 
imaging characteristics on MRI that may differentiate 
chondrosarcomas from chondroblastic osteosarcomas and 
other osteosarcomas is difficult due to overlapping imaging 
features (11). Tumor heterogeneity causes ADC values to 
be variable depending on the region of interest selected, 
with areas of higher cellularity and stroma demonstrating 
low ADC values (14). Although tumor heterogeneity on 
imaging suggests malignancy, it should not be considered a 
prerequisite (14). In the majority of cases histopathological 
confirmation is required. However, the tumor heterogeneity 
reflected by DWI and corresponding ADC maps may be 
helpful for planning of image guided biopsy (Figure 1).
Setting ADC cut-off values for benign and malignant 
tumors has also proven to be difficult which is in part due 
to variability in image acquisition protocols and technical 
specifications between vendors (15). A cut-off value of 
1.34×10−3 mm2/s proposed by one study (16) showed a 
sensitivity of 91% and specificity of 94% in differentiating 
between malignant and benign soft-tissue tumors. For cystic 
lesions, using a mean ADC value greater than 2.5×10−3 mm2/s 
led to a sensitivity of 80% and specificity of 100% (17), 
although the use of different imaging protocols can achieve 
higher ADC values of soft-tissue tumors (15). ADC values 
are usually lower in malignant tumors compared to benign 
tumors, but the overlap in values has made it impossible 
at this point to define ADC cut-offs with high sensitivity 
or specificity thus limiting its diagnostic value (15,18,19). 
Nevertheless, the features suggesting malignancy on DWI are 
areas of hyperintensity seen at high b values and corresponding 
hypointensity on ADC map (20).
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Research in the use of whole body DWI with background 
body signal suppression in localization of metastatic bone 
lesions and staging of tumors is showing good results and 
clinical applications are still being explored (21-23). DWI 
in comparison to positron emission tomography (PET) and 
scintigraphy has shown to be more effective in detecting 
metastatic bone tumors (24) while avoiding the need for 
isotopes which are in short supply (25). One study conducted 
a meta-analysis of 495 patients (26) and showed that whole-
body DWI is sensitive but not specific in detecting bone 
lesions. Whole-body MRI eliminates exposure to high-
doses of radiation, an important consideration especially if 
the patient is to undergo frequent imaging and is young (27). 
DWI has been shown to as effective or more effective in 
detecting metastatic prostate cancer, breast cancer and 
multiple myeloma in comparison to STIR-based protocols 
(28,29). Tumor localization when, conducting whole body 
diffusion, can be improved with overlay of anatomical 
imaging (Figure 2). Even though superimposing anatomical 
imaging on DWI images might be helpful for the clinician, it 
does not increase tumor detection rates (30).
The most common primary malignant tumor of the bone 
is intramedullary osteosarcoma (11). Yakushiji et al. (11) found 
that DWI may be more effective than gadolinium enhanced 
MRI in differentiating chondroblastic osteosarcomas and 
other osteosarcomas. Gadolinium enhanced MRI is important 
because the large chondroid component can make it difficult 
to biopsy appropriate regions containing malignant tumor 
cells (31,32). Missing chondroblastic osteosarcomas is not only 
impairing patient management but eventually clinical outcome. 
Patients with chondrosarcoma have a 5-year survival rate of 
72.6% when they receive appropriate treatment (33) whereas 
the 5-year survival rate for chondroblastic osteosarcomas is 
around 60% (34). MRI can assist in diagnosis of chondroblastic 
osteosarcoma (35), however, the septonodular and peripheral 
rim enhancement pattern often found in chondroblastic 
osteosarcomas can also be found in other chondroid matrix-
forming tumors (11,36). In the specimens studied by Yakushiji 
et al. (11), a heterogeneous pattern of MR enhancement was 
found in all chondroblastic osteosarcomas and other types of 
A B
C D
Figure 1 A 63-year-old female with a myxoid liposarcoma. Large parts of the tumor mass show strong contrast enhancement (A; B, with 
subtraction); the diffusion weighted imaging displays high signal especially in a nodular medial part of the tumor (C, white arrow) with 
corresponding low signal on the ADC map (D, white arrow). This part of the tumor contains the highest cellularity and should be chosen as 
a target for biopsy. 
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osteosarcoma, but was found in only 16.7% of chondrosarcoma 
cases. Minimum ADC values of osteosarcomas (n=17) was 
found to be (0.84±0.15) ×10−3 mm2/s while chondroblastic 
osteosarcomas (n=5) and chondrosarcomas (n=18) had 
minimum ADC values of (1.24±0.20) ×10−3 and (1.64±0.20) 
×10−3 mm2/s respectively. Even though the population size 
was small, the use of DWI in differentiating osteosarcomas 
from chondroblastic osteosarcomas and chondrosarcomas 
provided useful information based on the results of this study. 
Increased diagnostic accuracy may be possible if DWI is used in 
conjunction with morphological gadolinium enhanced MRI (11).
Bone marrow infiltration can be difficult to interpret 
because of the composition changes that occur with normal 
bone marrow over time. Yellow marrow is composed largely 
of adipose cells and its extent increases as a person ages. 
This occurs in a peripheral to central manner (37). Red 
marrow has increased water content and cellularity due to 
hematopoiesis. The bone marrow may change from yellow 
to red or it can be infiltrated by malignant cells (38,39). In 
normal yellow marrow, characteristic DWI findings include 
low ADC values seen along with signal suppression at higher 
b values on DWI (13). Red and yellow marrow can be mixed 
in the intramedullary space and when yellow is interspersed 
within red marrow, it is called islands of yellow marrow (37). 
This is an important consideration because medullary 
bone can appear to be heterogeneous on MRI and DWI. 
Replacement of bone marrow by malignant cells results 
in low ADC values (due to increased cellularity), however, 
increased signal can be seen at high b-value images (13). 
One study (40) investigated lymphomas infiltrating iliac 
bones and found that the use of DWI in conjunction with 
T1w spin echo results in a sensitivity of 77% and specificity 
of 92.5%. Although malignant tumors demonstrate high 
DWI signals and low ADC values, the study found red 
marrow can also demonstrate high signal intensity on DWI. 
It was also demonstrated in lymphomas infiltrating the iliac 
bone that T1-weighted images and STIR together provided 
a sensitivity and specificity of 85% and 97% respectively (40). 
Due to tendency of DWI to poor image quality and 
lower sensitivity and specificity, they suggested that bone 
lymphomas should be assessed using STIR and T1-weighted 
sequences. As in osteosarcomas, DWI can still play a role in 
whole-body imaging for localization of metastatic lesions and 
monitoring of tumor burden (21).
A B C D
E F G
Figure 2 MR of a 4-year-old male patient with left thoracic Ewing sarcoma, originating from the 7th rib with the following images: (A) T1w 
VIBE post gadolinium axial; (B) T1w TSE fat-saturated axial; (C) T2w TSE fat-saturated axial; (D) T2w HASTE sagittal; (E) DWI with 
b=1,000 axial; (F) corresponding ADC map axial; (G) fusion of T2w TSE fat-saturated axial + color coded DWI with b=1,000 axial. Images 
demonstrate mediastinal shift to the right site with left lung atelectasis, invasion of the left main bronchus, left lung, and posterior thoracic 
wall. Furthermore, invasion of the neuroforamina at T5-6, T6-7 and T7-8 levels and the central canal without cord compression is well 
appreciated on the fused images. The remainder of unaffected left lung is collapsed. Please note the heterogeneity of the tumor with regard 
to cellularity DWI and ADC images. MR, magnetic resonance; DWI, diffusion-weighted imaging; ADC, apparent diffusion coefficients.
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DWI may be helpful in differentiating between 
chronically expanding hematomas (CEH) and malignant 
soft tissue tumors (14). The term CEH was defined as a 
hematoma which ruptures and continues to grow for more 
than 1 month (41). On T1- and T2- weighted images, CEH 
can appear as a heterogeneous mass with a hypointense 
peripheral rim (42). Hemoglobin and red blood cell age 
found within the hematomas influence diffusion properties 
resulting in a heterogenous appearing mass on DWI (43), 
an important factor when considering intravascular blood 
and hemorrhagic components of the lesion (14). Calculating 
ADC maps, it was found that the mean ADC values of CEH 
[(1.55±0.121) ×10−3 mm2/s] compared to malignant soft-
tissue masses [(0.139±0.129) ×10−3 mm2/s] was significantly 
higher. They concluded that ADC values can be helpful to 
differentiate CEH from malignant soft-tissue masses (14).
Benign fibrous and fibrohistiocytic tumors are soft-
tissue tumors which are seen in different age groups (44). 
They can demonstrate characteristic features although it 
is possible for features of benign and malignant tumors 
to overlap resulting in misdiagnosis (45). Costa et al. (44) 
studied patients with histologically confirmed fibroblastic/
myofibroblastic/fibrohistiocytic soft tissue tumors who 
were grouped according to the WHO classification scheme 
as benign, intermediate and malignant. Comparison of 
the perfusion-insensitive diffusion coefficient showed 
a statistically significant difference between benign/
intermediate [(1.56±0.25) ×10−3 mm2/s] and malignant 
tumor groups [(0.89±0.15) ×10−3 mm2/s]. As previously 
discussed, overlap between ADC values is possible but the 
additional information from this sequence may allow a more 
comprehensive analysis of the lesion.
Knee injuries
MRI is frequently used to assess the soft-tissue components 
of the knee post injury. A recent study compared ADC 
mapping to MRI morphology imaging of the knee in partial 
and complete anterior cruciate ligament (ACL) tears (46). 
They found that specificity and sensitivity for with ADC 
maps was 96% and 94% respectively in diagnosing complete 
tears which was higher than the 87% and 50% specificity 
and sensitivity achieved when using T1 and T2 sequences 
with fat saturation. It was also found that the increase in 
specificity was statistically significant (P<0.01) but there 
was no statistically significant difference for sensitivity. 
Several studies investigated morphological changes on 
MRI to differentiate partial tears from complete tears 
and although certain features such as wavy ligaments 
or ligament thinning are suggestive of partial tears, 
determination of partial tears still remains a challenge 
(47-51). The difficulty in differentiating partial and complete 
tears can be partially attributed to the edema that results 
from the injury, which appears as a hyperintense signal on 
T2-weighted images, obscuring ligament fibers. It was found 
that applying DWI to traumatic injuries can improve the 
differentiation of partial and complete tears and that ADC 
mapping may be more useful than morphological MRI alone 
in differentiating partial and complete ACL tears (46).
Pre- and post-treatment assessment
Even though MRI is the method of choice for diagnosis 
and follow up of soft-tissue masses (52), assessing therapy 
response can be difficult with conventional MRI techniques 
because tissues can demonstrate post therapeutic cytotoxic 
as well as edematous changes on T2-weighted and STIR 
images (53-58). In clinical practice, often times therapeutic 
response is based on assessment of tumor size. However, 
the lack of reduction in tumor size does not necessarily 
reflect a lack of response to treatment, which is true 
particularly for osteosarcomas or other tumors with a large 
proportion of matrix (59). Assessment of pretreatment and 
post-treatment ADC values may be of prognostic value 
with regard to outcomes and may also reflect treatment 
response (Figure 3). Biologically aggressive tumors with 
areas of necrosis may have higher ADC values associated 
with a worse outcome (60). Areas with increased ADC 
values post-treatment can indicate areas of tumor cells 
which underwent necrosis suggesting a positive response 
to therapy (61). Chemotherapy or radiation can result in 
necrosis or apoptosis of tumor cells, altering water diffusion 
and possibly allowing an earlier, non invasive assessment 
of treatment response (13,44,60). An animal study 
regarding osteosarcoma showed that DWI can effectively 
differentiate between necrotic and viable tissue (62). 
Following treatment, osteosarcoma tissue undergoes 
necrosis and results in hyaline fibrosis and granulation 
tissue (63) which enhance on contrast enhanced images. 
Therefore it is difficult to assess treatment response using 
conventional imaging techniques (59). DWI may be capable 
of differentiating these morphological changes which 
would have been otherwise obscured (64) in addition to 
quantifying the amount of necrosis (65-67).
Studies have shown that increasing ADC values following 
treatment of primary sarcomas of the bone correlates with 
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successful treatment (68,69). Necrosis in Ewing sarcomas 
and osteosarcomas has been recognized as a favorable 
prognostic factor following treatment (25). Osteosarcomas 
with greater than 90% necrosis post-treatment were 
associated with better outcomes (68). In one study (69), 
histologically confirmed necrotic areas were correlated with 
ADC maps demonstrated a mean ADC value of 2.3 (±0.2) 
whereas viable tumor had a mean ADC value of 0.8 (±0.2). 
Increased ADC values following treatment have also been 
described for vertebral metastatic disease, with a change 
from a high signal to a low signal relative to normal vertebral 
bodies on DWI indicating a positive response to therapy (61).
Differentiation of inflammatory, infectious and 
malignant processes
Osteomyelitis and malignancy can have overlapping 
features with both appearing as hyperintense on DWI with 
low ADC values (10,70). In bacterial (7) and tuberculous 
osteomyelitis (71), the increase in inflammatory cells in the 
bone marrow causes an increase in the diffusion-weighted 
signal with a corresponding decrease in ADC values. 
Protein in fluids can restrict water motion, hence infectious 
processes (e.g., abscesses) and endometriotic cysts may 
appear as having restricted diffusion (13). Pui et al. (10) 
found that when using an ADC cutoff value of cutoff of 
1.02×10−3 mm2/s gave a sensitivity and specificity of 60.26% 
and 66% respectively. The low sensitivity and specificity of 
DWI do not make it useful for differentiating infection and 
malignant processes in a clinical setting.
Assessment of abscesses can be difficult using DWI because 
as with tumors, their imaging features may change over 
time. Initially, the increased cellular and protein content of 
the abscess causes restricted diffusion, seen as hyperintensity 
on DWI. As time progresses, the T2 shine-through effect 
can become dominant as the center of an abscess begins to 
liquefy (72). One study (73) investigated a group of 50 patients 
who were suspected of having a soft-tissue abscess, 32 of 
which were intramuscular, 14 intra-abdominal, 1 periorbital 
and 3 breast abscesses. All patients had material aspirated as a 
Figure 3 A 24-year-old female with osteosarcoma. (A-C) Conventional MRI reveals a solid osseous tumor mass in the left lateral femoral 
condyle with replacement of the normal marrow fat seen as bright T1 signal, an extraosseous soft tissue mass, and avid peripheral contrast 
enhancement; (D) DWI shows higher signal within the mass compared to normal bone in the medial condyle; the ADC values are low in 
the periphery of the mass, especially at its medial rim (E, white arrow); after initial chemotherapy of 8 weeks the ADC value of the medial 
rim has increased, indicating lower cellularity and therefore treatment response (F, white arrow). MRI, magnetic resonance imaging; DWI, 
diffusion-weighted imaging; ADC, apparent diffusion coefficients.
A
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confirmatory method. In this study DWI was shown to have 
a sensitivity and specificity of 92% and 80% respectively. 
Harish et al. (74) studied a group of eight patients and found 
that DWI, when used in conjunction with other imaging 
improved their confidence level for the diagnosis of abscess.
There have been a couple studies regarding the use of 
DWI for degenerative changes in the axial skeleton (6,7). 
Changes to the vertebral endplates may be the source of 
spine pain, in part due to disruption of diffusion of nutrients 
to the disc (75-78). Changes to the vertebral endplates are 
described according to their appearance on conventional 
T1 and T2 imaging using the Modic type classification 
system (76,79,80). One study investigated the use of 
DWI in differentiating endplate infectious causes from 
degenerative changes in the lumbar spine. ADC values in 
the infection group were found to be higher than in those 
with degenerative changes suggesting that DWI may be 
an additional tool for clinicians to differentiate between 
degenerative and infectious causes (9).
The reliance of intervertebral discs on diffusion for 
nutrients, not blood vessels, has suggested the possibility 
of using physical therapy in order to improve diffusion and 
ultimately clinical outcome. Applying mechanical pressure 
to the lumbar regions of patient significantly increased 
signal intensity on DWI (81). In a similar study (82), 
patients were asked to rate their pain after lumbar spine 
mobilization and those who reported immediate relief had a 
4.7% increase in diffusion while those who did not respond 
to the treatment had a decrease of 1.6% in diffusion. The 
increased signal on DWI theoretically correlates with 
increased molecular level diffusion within the disc and can 
potentially be used as a method for monitoring therapy 
response, however, due to the small sample sizes, further 
studies would be required.
It is estimated that anywhere from 0.3% to 1.9% of the 
population is affected by inflammatory spondyloarthritis 
(SpA) (7,83,84). Both SpA and degenerative causes of 
lower back pain are common in young patients and must 
be distinguished (7). DWI has shown to be effective 
in differentiating between acute degenerative lesions 
and early inflammatory sacroiliitis (85). Dallaudière 
et al. (7) conducted a study using DWI to assess patients 
with inflammatory spondyloarthritis and type 1 Modic 
change. When the disc is undergoing inflammation, it 
is described as Modic type 1 changes corresponding to 
an inflammatory stage of disk degenerative disease (80). 
Axial active inflammatory lesions showed significantly 
h igher  ADC va lues  (mean ,  0 .7888×10 −3 mm 2/ s ) 
compared to Modic changes (mean, 0.585×10−3 mm2/s) 
and normal subchondral bone (mean, 0.445×10−3 mm2/s). 
The difference in mean ADC values between subchondral 
bone and Modic changes was also statistically significant. 
Using a box-plot, the authors visually determined an 
optimal ADC cut-off value of 0.58×10−3 mm2/s. A different 
study (86) found that ADC values correlated with active 
ankylosing spondylitis suggesting that DWI may be used to 
monitor patient response to therapy and disease progression. 
Detection of synovitis in rheumatoid arthritis can be 
facilitated using DWI (Figure 4).
Compression fractures
Atraumatic vertebral compression fractures are common in 
the elderly population and may be secondary to osteoporosis, 
metastatic disease or other pathologies, therefore it is 
clinically important to determine their underlying cause (88). 
Depending on the etiology, vertebral compression fractures 
may have distinct radiographic features allowing a diagnosis 
to be readily made. However, overlapping imaging 
characteristics exist (89). Osteoporotic fractures tend to be 
hypo- to isointense when compared to normal vertebral 
bodies and malignant fractures tend to be hyperintense 
on DWI. The hypointensity in osteoporotic fractures is 
secondary to the edema while the hyperintensity seen in 
metastatic fractures is due to densely packed tumor cells 
restricting water diffusion. In their study, Baur et al. (90) 
used a diffusion-weighted steady-state free precession 
(SSFP) sequence which was acquired with various diffusion 
weightings. Reduction of false-positives was achieved by 
increasing the diffusion weighting, changing hyperintense 
osteoporotic fractures to a more hypointense appearance, a 
feature not seen in malignant compression fractures (90).
Zhou et al. (91) investigated the use of ADC maps and 
found that benign fractures showed higher ADC values 
when compared to metastatic fractures, with values of 
(3.2±0.5) ×10−3 and (1.9±0.3) ×10−4 mm2/s respectively. 
Although, this result has been found in several other 
studies (10,61,92,93), there is overlap between ADC 
values depending on imaging protocols, and no cut-off 
can be determined at this point (13). Again, tumors tend 
to demonstrate lower ADC values due to their cellularity 
in the early stages of growth while in later stages when 
necrosis predominates, increased ADC values may be seen. 
The DWI results should be combined with morphologic 
MR findings and other functional imaging modalities such 
as PET, for instance when using the novel hybrid imaging 
747Quantitative Imaging in Medicine and Surgery, Vol 5, No 5 October 2015
© Quantitative Imaging in Medicine and Surgery. All rights reserved. Quant Imaging Med Surg 2015;5(5):740-753www.amepc.org/qims
technology PET/MRI (Figure 5). False-negatives can arise 
when the lesions are sclerotic (13) demonstrating low 
signal on conventional MRI and DWI due to the increased 
fibrotic content of the lesion.
Limitations of DWI
DWI has limitations including susceptibility, motion, and 
arterial pulsation artifacts, requiring imaging protocols 
modifications in order to limit the amount of noise (59,72). 
Diffusion MRI is more sensitive to motion in comparison 
to other sequences, a problem which has been minimized 
by the use of echo-planar imaging. Echo-planar imaging, 
however, provides lower spatial resolution images and is 
more susceptible to eddy currents (94). These artifacts from 
eddy currents are introduced at bone-tissue and air-tissue 
interfaces (95). Patient motion can cause voxels to change 
position, an especially important consideration when taking 
multiple images at different b-values to calculate ADC 
maps. Calculating ADC maps also requires the assumption 
that voxels have a certain size when in fact they vary 
according to the local diffusion gradient strength (94). At 
times, depending on the imaging technique used it may not 
be possible to calculate an ADC map, such as with a SSFP 
sequence (90). 
Pitfalls of DWI
There are several challenges that are associated with the 
creation and interpretation of DWI. The guidelines for 
choosing a region of interest are not well-established even 
though tumors are often heterogeneous. As discussed, post-
therapy with mixed viable tumor and areas of necrosis lead 
to inter-reader differences (12). One study using multiple, 
small regions of interest and minimum ADC values, found 
extensive variability within the tumor (14). The usage of 
minimum ADC values is suggested because the regions of 
interest with the lowest ADC values theoretically correlate 
D
A B C
E F
Figure 4 A 74-year-old female with late-onset rheumatoid arthritis with the following MR images: (A) T1w coronal; (B) T1w fat 
suppressed post gadolinium coronal; (C) T1w fat suppressed post gadolinium axial; (D) DWI with b=50 axial; (E) DWI with b=800 axial and 
corresponding ADC map color coded axial. Morphologic findings include radiocarpal and distal radioulnar joint space narrowing as well as 
enhancement of the synovium. Please note that although some authors (87) advocate DWI as a novel non-invasive approach to contrast-free 
imaging of synovitis, the signal hyperintensity on DWI with corresponding high ADC-values reflects mainly T2-shine-through-effects and 
does not represent true diffusion restriction. DWI, diffusion-weighted imaging; ADC, apparent diffusion coefficients.
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well with regions of high cellularity (14) and can possibly 
indicate regions which did not respond to therapy.
B values are influenced by the gyromagnetic ratio, 
gradient strength, diffusion gradient duration, and time 
between diffusion gradient pulses, all of which influence the 
ADC values (12). Taking into consideration the variation in 
MRI specifications between vendors and imaging protocols 
used in different institutions, it is challenging to standardize 
b values and the calculated ADC values. Depending on the 
location of the tumor, artifacts may appear at bone-tissue or 
air-tissue interfaces therefore modified imaging protocols 
may be required (95). Tumors can also appear similar to 
simple fluid on T2-weighted images due to the T2-shine 
through effect (64). Ideally, DWI should be correlated with 
ADC maps (96). Table 1 lists clinically important pitfalls 
associated with DWI.
Table 1 Clinically important pitfalls in DWI
Pitfalls associated with DWI
T2-shine through effect
Non-standardized MRI and image acquisition techniques
Lack of collaboration between vendors
Different imaging protocols and processing models (e.g., mono-exponential modeling)
No pre-defined b values for a given tumor or its location (61)
Perfusion and diffusion components contributing to varying DWI signal, adding to the complexity in interpretation (13)
DWI, diffusion-weighted imaging; MRI, magnetic resonance imaging.
Figure 5 A 16-year-old male patient with osteosarcoma of the mid femoral shaft who was imaged with whole-body FDG-PET/MRI (Siemens, 
Biograph mMR). PET acquisition was performed 67 min post FDG injection. The following images are provided: (A) whole body PET 
maximum-intensity projection; (B) T2w HASTE axial; (C) fusion of T2w HASTE axial and FDG-PET axial; (D) T1w VIBE axial; (E) 
DWI with b=50 axial; (F) DWI with b=800 axial; (G) corresponding ADC map axial. The FDG avid malignancy is seen on AP planar whole 
body image within the left femoral diaphysis. Within the medial aspect of the tumor there is increased signal on T2WI, high b value DWI, 
and corresponding low signal on ADC map consistent with area of high grade tumor cellularity. PET and DWI images demonstrate the 
marked heterogeneity of the tumor with necrotic areas and other highly cellular tumor. PET, positron emission tomography; MRI, magnetic 
resonance imaging; DWI, diffusion-weighted imaging; ADC, apparent diffusion coefficients; HASTE, half-Fourier acquisition single-shot; 
VIBE,  volumetric interpolated breath-hold examination.
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Conclusions and future directions
DWI has been shown to add value in several areas by being 
part of the multi-parametric MRI approach, even though 
quantitative values tend to overlap. Investigations into the 
clinical applications regarding monitoring tumor burden or 
whole-body imaging are still at an early stage. A challenge 
that DWI faces is standardization of imaging protocols 
allowing for better comparisons across studies. Therefore, 
initiatives like the Quantitative Imaging Biomarkers 
Alliance (QIBA) organized by RSNA are very promising. It 
is also uncertain whether therapies other than those which 
cause apoptosis or ischemia and essentially associated with 
alterations in cellularity, are capable of being measured by 
DWI (60).
Currently, studies have shown that DWI can be used 
for various musculoskeletal pathologies and is showing 
promising results in a variety of applications. It has been 
demonstrated that MRI can be useful in differentiating 
partial and complete ACL tears (46). The diffusion 
properties of tumors pre- and post-treatment can be used 
to assess the prognosis of patients who have soft-tissue 
tumors (59,60). The effects of increased cellularity of 
tumors on diffusion can also be exploited to localize soft-
tissue tumors and bone lesions (26). The use of DWI in 
differentiating infectious from malignant causes is limited 
due to overlapping imaging characteristics (10) but has 
shown utility in differentiating osteoporotic and metastatic 
compression fractures (5). It will be crucial to correlate 
DWI with morphology on MRI and other functional 
techniques, such as PET as suggested when applying PET/
MRI for musculoskeletal applications (97,98).
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